Structure of a cannabinoid receptor and functional expression of the cloned cDNA
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner. Although CNS depression and analgesia are well documented effects of the cannabinoids, the mechanisms responsible for these and other cannabinoid-induced effects are not so far known. The hydrophobic nature of these substances has suggested that cannabinoids resemble anaesthetic agents in their action, that is, they nonspecifically disrupt cellular membranes. Recent evidence, however, has supported a mechanism involving a G protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids. Here we report the cloning and expression of a complementary DNA that encodes a G protein-coupled receptor with all of these properties. Its messenger RNA is found in cell lines and regions of the brain that have cannabinoid receptors. These findings suggest that this protein is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary psychoactive constituent of cannabis, THC (Mechoulam and Gaoni, 1965), and certain other plant-derived or synthetic psychoactive cannabinoids bind cannabinoid (CB 1 and CB 2 ) receptors (Devane et al, 1988;Matsuda et al, 1990;Munro et al, 1993).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Matsuda et al, 1990
In the citing paper
“Cannabinoids, like many analgesics and recreational drugs, act on the brain’s reward pathways. Cannabinoid-1 receptors (CB1R) are co-localized with the opioid receptors on the dopaminergic cells of the nucleus accumbens, probably the most important structure in human reward pathways, which partly overlaps the antinociceptive pathways [30–32].”
From Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial (2012) · cites this paper as [30]
In the citing paper
“Both CB12 and CB23 receptors are G-coupled protein receptors that are negatively coupled to adenylate cyclase.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [2]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
G proteins and dual control of adenylate cyclase
Gilman, A. G. (1984) · Cell · doi:10.1016/0092-8674(84)90336-2 · Cited by 1,802
Identification of a Family of Muscarinic Acetylcholine Receptor Genes
Bonner, T. I., Buckley, N. J., Young, A. C., & Brann, M. R. (1987) · Science · doi:10.1126/science.3037705 · Cited by 1,427
Self-citationA cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.
Okayama, H., & Berg, P. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.2.280 · Cited by 933
Lutropin-Choriogonadotropin Receptor: An Unusual Member of the G Protein-Coupled Receptor Family
McFarland, K. C., Sprengel, R., Phillips, H. S., Köhler, M., Rosemblit, N., Nikolics, K., Segaloff, D. L., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2502842 · Cited by 929
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Self-citationcDNA eloping of bovine substance-K receptor through oocyte expression system
Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., & Nakanishi, S. (1987) · Nature · doi:10.1038/329836a0 · Cited by 742
Cloning and Sequencing of Porcine LH-hCG Receptor cDNA: Variants Lacking Transmembrane Domain
Loosfelt, H., Misrahi, M., Atger, M., Salesse, R., Vu Hai-Luu Thi, M. T., Jolivet, A., Guiochon-Mantel, A., Sar, S., Jallal, B., Garnier, J., et al. (1989) · Science · doi:10.1126/science.2502844 · Cited by 559
Research works printed but not linked: 14
- Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
- Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
- Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
- Howlett, A. C. Molec. Pharmacol. 27, 429–436 (1985).
- Howlett, A. C. & Fleming, R. M. Molec. Pharmacol. 26, 532–538 (1984).
- Howlett, A. C., Qualy, J. M. & Khachatrian, L. L. Molec. Pharmacol. 29, 307–313 (1986).
- Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
- Howlett, A. C., Johnson, M. R., Melvin, L. S. & Milne, G. M. Molec. Pharmacol. 33, 297–302 (1988).
- Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
- Lawrence, D. K. & Gill, E. W. Molec. Pharmacol. 11, 595–602 (1975).
- Hillard, C. J., Harris, R. A. & Bloom, A. S. J. Pharmac. exp. Ther. 232, 579–588 (1985).
- Okayama, H. & Berg, P. Molec. cell. Biol. 3, 280–289 (1983).
- Chen, C. & Okayama, H. Molec. cell. Biol. 7, 2745–2752 (1987).
- Brooker, G., Harper, J. F., Terasaki, W. L. & Moylan, R. D. Adv. Cyclic Nucleotide Res. 10, 1–33 (1979).
Cited by
Items 401–500 of 1,050
Bridges, D., Ahmad, K., & Rice, A. S. C. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704110 · Cited by 221
Retrograde signaling by endocannabinoids
Kreitzer, A. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00328-8 · Cited by 222
Barann, M., Molderings, G., Brüss, M., Bönisch, H., Urban, B. W., & Göthert, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704829 · Cited by 215
Regulation of PI3K/Akt/GSK‐3 pathway by cannabinoids in the brain
Ozaita, A., Puighermanal, E., & Maldonado, R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04642.x · Cited by 216
Devane, W. A., & Axelrod, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6698 · Cited by 220
Cannabis use in young people: The risk for schizophrenia
Casadio, P., Fernandes, C., Murray, R. M., & Di Forti, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.007 · Cited by 206
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
Anand, P., Whiteside, G., Fowler, C. J., & Hohmann, A. G. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.003 · Cited by 218
New perspectives on enigmatic vanilloid receptors
Szallasi, A., & Di Marzo, V. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01630-1 · Cited by 216
Baron, E. P. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 206
Paparelli, A., Di Forti, M., Morrison, P. D., & Murray, R. M. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00001 · Cited by 216
Pertwee, R. G. (2005) · The AAPS Journal · doi:10.1208/aapsj070364 · Cited by 203
The Cannabinoid System and Cytokine Network
Klein, T. W., Lane, B., Newton, C. A., & Friedman, H. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22501.x · Cited by 214
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
Pacher, P., & Haskó, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707582 · Cited by 217
Endocannabinoid mechanisms of pain modulation
Hohmann, A. G., & Suplita, R. L. (2006) · The AAPS Journal · doi:10.1208/aapsj080479 · Cited by 212
Zarruk, J. G., Fernández-López, D., García-Yébenes, I., García-Gutiérrez, M. S., Vivancos, J., Nombela, F., Torres, M., Burguete, M. C., Manzanares, J., Lizasoain, I., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.631044 · Cited by 215
Aberrant cannabinoid signaling impairs oviductal transport of embryos
Wang, H., Guo, Y., Wang, D., Kingsley, P. J., Marnett, L. J., Das, S. K., DuBois, R. N., & Dey, S. K. (2004) · Nature Medicine · doi:10.1038/nm1104 · Cited by 217
Marzo, V. D., Melck, D. J., Orlando, P., Bisogno, T., Zagoory, O., Bifulco, M., Vogel, Z., & PETROCELLIS, L. D. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580249 · Cited by 212
Activational role of cannabinoids on movement
Sañudo-Peña, M. C., Romero, J., Seale, G. E., Fernandez-Ruiz, J. J., & Walker, J. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00044-3 · Cited by 210
Straiker, A., Stella, N., Piomelli, D., Mackie, K., Karten, H. J., & Maguire, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14565 · Cited by 211
The obesity pipeline: current strategies in the development of anti-obesity drugs
Cooke, D., & Bloom, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2136 · Cited by 211
The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling
Bayewitch, M., Avidor-Reiss, T., Levy, R., Barg, J., Mechoulam, R., & Vogel, Z. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01207-u · Cited by 210
Uhlenbrock, K., Gassenhuber, H., & Kostenis, E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00041-4 · Cited by 213
Adverse effects of cannabis and cannabinoids
Ashton, C. H. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/83.4.637 · Cited by 214
The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
Rueda, D., Galve-Roperh, I., Haro, A., & Guzmán, M. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23114-x · Cited by 200
The Endocannabinoid System, Cannabinoids, and Pain
Fine, P. G., & Rosenfeld, M. J. (2013) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10129 · Cited by 178
Shoemaker, J. L., Seely, K. A., Reed, R. L., Crow, J. P., & Prather, P. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04346.x · Cited by 207
Schmidt, B. L., Hamamoto, D. T., Simone, D. A., & Wilcox, G. L. (2010) · Molecular Interventions · doi:10.1124/mi.10.3.7 · Cited by 193
The endocannabinoid signalling system: Biochemical aspects
BISOGNO, T., LIGRESTI, A., & DIMARZO, V (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.027 · Cited by 201
The endocannabinoid system and cancer: therapeutic implication
Guindon, J., & Hohmann, A. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01327.x · Cited by 200
Häuser, W., Finn, D. P., Kalso, E., Krcevski‐Skvarc, N., Kress, H., Morlion, B., Perrot, S., Schäfer, M., Wells, C., & Brill, S. (2018) · European Journal of Pain · doi:10.1002/ejp.1297 · Cited by 199
Endocannabinoids and Synaptic Function in the CNS
Hashimotodani, Y., Ohno-Shosaku, T., & Kano, M. (2007) · The Neuroscientist · doi:10.1177/1073858406296716 · Cited by 205
Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor
Griffin, G., Tao, Q., & Abood, M. E. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35367-4 · Cited by 207
Leterrier, C., Lainé, J., Darmon, M., Boudin, H., Rossier, J., & Lenkei, Z. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5437-05.2006 · Cited by 201
Vickers, S. P., Webster, L. J., Wyatt, A., Dourish, C. T., & Kennett, G. A. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1384-8 · Cited by 207
Mitrirattanakul, S., Ramakul, N., Guerrero, A. V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K. F., & Spigelman, I. (2006) · Pain · doi:10.1016/j.pain.2006.06.016 · Cited by 207
“The targets of the antinociceptive cannabinoids may be defined by the distribution of two cloned subtypes of cannabinoid receptors, CB1R and CB2R (Matsuda et al., 1990; Munro et al., 1993).”
BackgroundInfluentialCrystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1
Chrencik, J. E., Roth, C. B., Terakado, M., Kurata, H., Omi, R., Kihara, Y., Warshaviak, D., Nakade, S., Asmar-Rovira, G., Mileni, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.002 · Cited by 204
Progress in brain cannabinoid CB2 receptor research: From genes to behavior
Jordan, C. J., & Xi, Z.-X. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.026 · Cited by 197
Pitsillou, E., Bresnehan, S. M., Kagarakis, E. A., Wijoyo, S. J., Liang, J., Hung, A., & Karagiannis, T. C. (2020) · Molecular Biology Reports · doi:10.1007/s11033-019-05129-3 · Cited by 206
Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice
Martellotta, M. C., Cossu, G., Fattore, L., Gessa, G. L., & Fratta, W. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00052-9 · Cited by 202
Discovery and characterization of endogenous cannabinoids
Martin, B. R., Mechoulam, R., & Razdan, R. K. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00281-7 · Cited by 202
Cannabinoid Addiction: Behavioral Models and Neural Correlates
Maldonado, R., & Rodrı́guez de Fonseca, F. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03326.2002 · Cited by 205
Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones
Straiker, A., & Mackie, K. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.091918 · Cited by 201
Dysregulated Cannabinoid Signaling Disrupts Uterine Receptivity for Embryo Implantation
Paria, B. C., Song, H., Wang, X., Schmid, P. C., Krebsbach, R. J., Schmid, H. H. O., Bonner, T. I., Zimmer, A., & Dey, S. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100679200 · Cited by 201
Self-citationHohmann, A. G., & Herkenham, M. A. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200007)37:1<71::aid-syn8>3.0.co;2-k · Cited by 225
The endogenous cannabinoid system and its role in nociceptive behavior
Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203
“In the early 1990s, two G-protein– coupled receptors (GPCRs), CB1 (Matsuda et al., 1990) and CB2 (Munro et al.”
BackgroundInhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
Ross, H. R., Napier, I., & Connor, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707104200 · Cited by 199
Cannabinoids and Pain: Sites and Mechanisms of Action
Starowicz, K., & Finn, D. P. (2017) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.05.003 · Cited by 193
Inhibitors of arachidonoyl ethanolamide hydrolysis.
Koutek, B., Prestwich, G. D., Howlett, A. C., Chin, S. A., Salehani, D., Akhavan, N., & Deutsch, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31599-5 · Cited by 201
Wu, C.-S., Jew, C. P., & Lu, H.-C. (2011) · Future Neurology · doi:10.2217/fnl.11.27 · Cited by 190
Rosenberg, E. C., Patra, P. H., & Whalley, B. J. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.11.006 · Cited by 193
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
An, D., Peigneur, S., Hendrickx, L. A., & Tytgat, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145064 · Cited by 193
Hájos, N., & Freund, T. F. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00157-0 · Cited by 202
Cloning and molecular characterization of the rat CB2 cannabinoid receptor
Brown, S. M., Wager-Miller, J., & Mackie, K. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00341-x · Cited by 190
Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain
Breivogel, C. S., Sim, L. J., & Childers, S. R. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36967-8 · Cited by 202
Lake, K. D., Compton, D. R., Varga, K., Martin, B. R., & Kunos, G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36714-x · Cited by 221
Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase
Rhee, M.-H., Vogel, Z., Barg, J., Bayewitch, M., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 191
Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide
Varga, K., Lake, K., Martin, B. R., & Kunos, G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00181-j · Cited by 201
Re, G., Barbero, R., Miolo, A., & Di Marzo, V. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2005.10.003 · Cited by 199
Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine
Halpin, L. E., Collins, S. A., & Yamamoto, B. K. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.07.014 · Cited by 194
Cannabinoid receptors undergo axonal flow in sensory nerves
Hohmann, A. G., & Herkenham, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00220-1 · Cited by 194
Cellular accumulation of anandamide: consensus and controversy
Hillard, C. J., & Jarrahian, A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705468 · Cited by 203
Wiley, J. L., Marusich, J. A., & Huffman, J. W. (2014) · Life Sciences · doi:10.1016/j.lfs.2013.09.011 · Cited by 194
The Functional Neuroanatomy of Brain Cannabinoid Receptors
Breivogel, C. S., & Childers, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0229 · Cited by 197
Sánchez, C., Galve-Roperh, I., Rueda, D., & Guzmán, M. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.5.834 · Cited by 192
Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia
Mátyás, F., Yanovsky, Y., MacKie, K., Kelsch, W., Misgeld, U., & Freund, T. F. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.005 · Cited by 190
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
Basu, S., & Dittel, B. N. (2011) · Immunologic Research · doi:10.1007/s12026-011-8210-5 · Cited by 192
Schreuder, T. C., Verwer, B. J., Nieuwkerk, C. M. V., & Mulder, C. J. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2474 · Cited by 191
Martínez, V., Iriondo De-Hond, A., Borrelli, F., Capasso, R., del Castillo, M. D., & Abalo, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093067 · Cited by 180
Mechanism of Extracellular Signal-Regulated Kinase Activation by the CB1 Cannabinoid Receptor
Galve-Roperh, I., Rueda, D., Gómez del Pulgar, T., Velasco, G., & Guzmán, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1385 · Cited by 185
The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling.
Paria, B. C., Das, S. K., & Dey, S. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.21.9460 · Cited by 200
Cyclooxygenase-2 in synaptic signaling
Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195
Racz, I., Nadal, X., Alferink, J., Baños, J. E., Rehnelt, J., Martín, M., Pintado, B., Gutierrez-Adan, A., Sanguino, E., Manzanares, J., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3400-08.2008 · Cited by 195
Lim, G., Sung, B., Ji, R.-R., & Mao, J. (2003) · Pain · doi:10.1016/s0304-3959(03)00242-2 · Cited by 195
“Two major cannabinoid receptor subtypes, namely cannabinoid-1 (CB1R) and cannabinoid-2 (CB2R) receptors, have been cloned (Devane et al., 1988; Matsuda et al., 1990; Munro et al., 1993).”
BackgroundLutz, B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.007 · Cited by 192
Wang, Q., Peng, Y., Chen, S., Gou, X., Hu, B., Du, J., Lu, Y., & Xiong, L. (2009) · Stroke · doi:10.1161/strokeaha.108.541490 · Cited by 193
Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
Labar, G., Bauvois, C., Borel, F., Ferrer, J., Wouters, J., & Lambert, D. M. (2010) · ChemBioChem · doi:10.1002/cbic.200900621 · Cited by 185
Observational analysis of feeding induced by Δ9-THC and anandamide
WILLIAMS, C., & KIRKHAM, T. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00725-4 · Cited by 194
Dopamine and Glutamate in Huntington's Disease: A Balancing Act
André, V. M., Cepeda, C., & Levine, M. S. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00134.x · Cited by 189
Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation
Scandiffio, R., Geddo, F., Cottone, E., Querio, G., Antoniotti, S., Gallo, M. P., Maffei, M. E., & Bovolin, P. (2020) · Nutrients · doi:10.3390/nu12113273 · Cited by 177
Enhancement of memory in cannabinoid CB1 receptor knock-out mice
Reibaud, M., Obinu, M. C., Ledent, C., Parmentier, M., Böhme, G. A., & Imperato, A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00496-3 · Cited by 188
Hutcheson, D. M., Tzavara, E. T., Smadja, C., Valjent, E., Roques, B. P., Hanoune, J., & Maldonado, R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702228 · Cited by 192
Julian, M. D., Martin, A. B., Cuellar, B., Rodriguez De Fonseca, F., Navarro, M., Moratalla, R., & Garcia-Segura, L. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00070-8 · Cited by 188
Cannabinoid Receptors and Their Role in Neuroprotection
van der Stelt, M., & Di Marzo, V. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:037 · Cited by 189
Cannabis, cannabinoids and reproduction
Park, B., McPartland, J. M., & Glass, M. (2004) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.007 · Cited by 192
Onaivi, E. S. (2006) · Neuropsychobiology · doi:10.1159/000100778 · Cited by 191
Hillard, C. J., Weinlander, K. M., & Stuhr, K. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.020 · Cited by 187
Biology of endocannabinoid synthesis system
Wang, J., & Ueda, N. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.12.002 · Cited by 180
Ribeiro, A., Ferraz-de-Paula, V., Pinheiro, M. L., Vitoretti, L. B., Mariano-Souza, D. P., Quinteiro-Filho, W. M., Akamine, A. T., Almeida, V. I., Quevedo, J., Dal-Pizzol, F., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.043 · Cited by 185
De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis
del Pulgar, T. G., Velasco, G., Sánchez, C., Haro, A., & Guzmán, M. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630183 · Cited by 186
Pan, X., Ikeda, S. R., & Lewis, D. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1064 · Cited by 185
Endocannabinoid system, stress and HPA axis
Micale, V., & Drago, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.039 · Cited by 189
Minor Cannabinoids: Biosynthesis, Molecular Pharmacology and Potential Therapeutic Uses
Walsh, K. B., McKinney, A. E., & Holmes, A. E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.777804 · Cited by 208
Melck, D., Bisogno, T., De Petrocellis, L., Chuang, H.-H., Julius, D., Bifulco, M., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1105 · Cited by 188
The endocannabinoid system as a target for the treatment of neurodegenerative disease
Scotter, E. L., Abood, M. E., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00735.x · Cited by 179
Brain Cannabinoid CB2 Receptor in Schizophrenia
Ishiguro, H., Horiuchi, Y., Ishikawa, M., Koga, M., Imai, K., Suzuki, Y., Morikawa, M., Inada, T., Watanabe, Y., Takahashi, M., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.024 · Cited by 184
Jutras-Aswad, D., DiNieri, J. A., Harkany, T., & Hurd, Y. L. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0027-z · Cited by 184
Endocannabinoids in the retina: From marijuana to neuroprotection
Yazulla, S. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.07.002 · Cited by 177
N-arachidonoyl l-serine, an endocannabinoid-like brain constituent with vasodilatory properties
Milman, G., Maor, Y., Abu-Lafi, S., Horowitz, M., Gallily, R., Batkai, S., Mo, F.-M., Offertaler, L., Pacher, P., Kunos, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510676103 · Cited by 187
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Morales, P., Reggio, P. H., & Jagerovic, N. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00422 · Cited by 178
Shearman, L. P., Rosko, K. M., Fleischer, R., Wang, J., Xu, S., Tong, X. S., & Rocha, B. A. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200312000-00001 · Cited by 186
Metadata
- Authors
- Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Lolait, Stephen J.
- Venue
- Nature
- Published
- 1990-08-09
- Volume
- 346
- Issue
- 6284
- Pages
- 561-564
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075894678
- Cited by
- 5,011
- References
- 20
- Citations by year
- 2026: 47 · 2025: 84 · 2024: 105 · 2023: 141 · 2022: 129 · 2021: 205 · 2020: 185 · 2019: 171 · 2018: 153 · 2017: 169 · 2016: 172 · 2015: 176 · 2014: 184 · 2013: 190 · 2012: 200
- FWCI
- 53.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, G protein-coupled receptors, cDNA cloning, receptor structure, adenylate cyclase inhibition, pertussis toxin sensitivity, cannabis, central nervous system effects, brain mRNA expression
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Base Sequence, Binding, Competitive, Cannabinoids, Cell Line, Cerebral Cortex, Cloning, Molecular, Colforsin, Kinetics, Molecular Sequence Data, Receptors, Drug, Transfection, Gene Library, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.